Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 1.000 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.553 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.550 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.518 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.517 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.515 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.515 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.510 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.504 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.502 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.501 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.499 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.498 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.497 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.495 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.494 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.487 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.487 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.487 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.484 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.484 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.483 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.483 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.483 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.481 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.480 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.476 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.474 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.474 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.470 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.468 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.467 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.466 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.466 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.464 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
| 4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.463 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.462 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.460 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.460 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.459 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.459 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.458 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
| 4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.454 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.453 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.452 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.450 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.448 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.447 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.447 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.446 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.445 | |
| 3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 3w0n | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.443 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.442 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.441 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.441 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.440 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |